888.552.6760 SCHEDULE A CONSULTATION
Cancer-Center-360-Blog

Cancer treatment

155 Posts

KRAS mutations

July 27, 2021

Drug approval underscores the challenges of KRAS mutations in cancer

For all the advancements in targeted therapy, some targets remain elusive—among them, genes in the troublesome RAS family.

READ FULL POST
HRD and PARP inhibitors

July 22, 2021

Targeting the HRD biomarker may improve outcomes for ovarian cancer patients

Doctors have identified a genetic feature—or biomarker—called homologous recombination deficiency that’s leading to positive outcomes for patients with ovarian cancer.

READ FULL POST
Telehealth

July 13, 2021

Telehealth post-pandemic: Video doctor visits look like they’re here to stay

Telehealth may provide advantages for physicians and other health providers, especially when used in combination with in-office appointments.

READ FULL POST
Care team

July 6, 2021

Who is on your cancer care team?

When a patient walks through a door of a cancer center, he or she may follow any number of paths to get diagnosed and treated.

READ FULL POST
Cancer disparities

June 17, 2021

Creating a level playing field in the fight against cancer

Disparities in cancer risk, incidences and deaths among Americans span many racial, ethnic and socio-economic lines.

READ FULL POST
Clinical trials

June 15, 2021

Are cancer clinical trials safe? Answers to common patient concerns

Thinking of participating in a cancer clinical trial? This article explains how they work, who they're for, and the risks and benefits for patients.

READ FULL POST
Ovarian cancer

June 3, 2021

What’s the difference? Ovarian, fallopian tube and primary peritoneal cancers

Ovarian, fallopian tube and primary peritoneal cancers are the most common cause of death in women with cancer of the reproductive system

READ FULL POST
Car T-cell therapy

June 1, 2021

Three things you need to know about CAR T-cell therapy

CAR T-cell therapy may transform some cancers from acute diseases with poor outcomes to chronic illnesses that may be managed with more positive results.

READ FULL POST
Radiopharmaceuticals

May 27, 2021

Radiopharmaceuticals designed to take radiation directly to the cancer

Oncologists have shown increasing interest in radiophamaceuticals—radioactive particles attached to drugs that are designed to precisely target and kill cancer cells.

READ FULL POST

The information contained in this blog is not intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition. Nothing contained in the blog is intended to be used for medical diagnosis or treatment of any illness, condition or disease.

READ OUR COMMUNITY GUIDELINES >>

Sign up to receive our monthly newsletter